On the edge of precision medicine in respiratory disease

This Grand Round will not only delve into the latest developments in precision medicine but also provide a platform for discussion on its application in managing respiratory diseases.

• The current landscape and advancements in precision medicine and its relevance to respiratory care.
• Key research initiatives and public-private partnerships, such as P4O2, aimed at enhancing treatment approaches.
• The implications of precision medicine for future clinical practices and patient outcomes.

Prof. Dr. A.H. Maitland-Van der Zee (Anke-Hilse) published more than 340 international publications in international scientific journals, and she is in the lead of a research group of 40 people.

Maitland-van der Zee is the principal investigator of P4O2,  a large public private partnership in the Netherlands. She has been the president of the Netherlands Respiratory Society, FIGON (Federation of Innovative Drug research in the Netherlands) and EASYM (European Association of Systems Medicine). She was recently elected in the executive committee of the European Federation of Pharmaceutical Sciences.